BMY
2025Q4BMOBristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS1.20
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.7%
IV front—
P/C full—
P/C front—
Features as of2026-02-04
Run-up
Close—
Ret 5d+5.5%
Ret 10d+5.7%
Ret 20d+5.9%
Ret 30d+6.3%
Actual EPS
1.26Beat
Estimated EPS1.20
Actual revenue
12.5B
Surprise %+5.0%
Beat / missBeat
Beat streak 44
Beat streak 87
Reaction
1-day stock reaction+1.0%
Implied vs actual
Implied 1.7%Actual 2.2%
Gap reaction+2.2%
Day result+3.3%
Next-day upYes
Realized / IV1.33×
Post tape
Post 5d+0.6%
Post 10d+1.9%
Post volume23.9M
Vol ×10d1.92×
Vol ×20d1.85×
Post range4.3%